Boris Hadaschik

24.2k citations

419 papers · 13.1k indexed · 9 hit papers · h-index 56

Impact in

Pulmonary and Respiratory Medicine top 0.05%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Radiology, Nuclear Medicine and Imaging top 0.05%
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging

Papers in

Pulmonary and Respiratory Medicine 304
- Prostate Cancer Treatment and Research 212
- Prostate Cancer Diagnosis and Treatment 159
- Renal cell carcinoma treatment 29
Urology 42

Co-authors: Uwe Haberkorn Markus Hohenfellner Ali Afshar‐Oromieh Frederik L. Giesel Klaus Kopka Matthias Eder Jan Philipp Radtke Jürgen Debus
Journals: Journal of Clinical Oncology (38 papers)The Journal of Urology (25 papers)Journal of Nuclear Medicine (24 papers)European Journal of Nuclear Medicine and Molecular Imaging (20 papers)British Journal of Urology (19 papers)
Partner nations: Germany United States Canada

In The Last Decade

Boris Hadaschik

393 papers receiving 12.9k citations

Hit Papers

9 papers align trajectories log scale

Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches 2023 · 80 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Cancers
2023 European Urology
2018 New England Journal of Medicine
2017 Journal of Nuclear Medicine
2016 European Urology
2016 European Journal of Nuclear Medicine and Molecular Imaging
2014 European Journal of Nuclear Medicine and Molecular Imaging
2014 European Urology
2013 European Journal of Nuclear Medicine and Molecular Imaging

Peers

Countries citing papers authored by Boris Hadaschik

Since Specialization

Citations

This map shows the geographic impact of Boris Hadaschik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Hadaschik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Hadaschik more than expected).

Fields of papers citing papers by Boris Hadaschik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Hadaschik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Hadaschik. The network helps show where Boris Hadaschik may publish in the future.

Co-authors

The 25 scholars most cited alongside Boris Hadaschik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Boris Hadaschik Line = papers co-authored together Boris Hadaschik links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Transcriptomic Profiling of the Tumor Immune Microenvironment Reveals Prognostic Markers in mCRPC Patients Treated with LuPSMA Therapy Theranostics ·S. Riazantsev, 서만덕, N.I. RAZROYEV, Christopher Darr, Elai Davicioni, Kuangyu Shi, Tsutomu Ikenohira, Mynga Futrell, J. Gallissian, Katharina Lückerath, Boris Hadaschik, Robert Seifert	2025	0
2	Screening for Prostate Cancer with Prostate-specific Antigen European Urology Open Science ·S. S. Kim, Peter Albers, Boris Hadaschik	2024	0
3	Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial) Journal of Nuclear Medicine ·Rafael Benevenuto dos Santos Caetano, W. J. Percival, Lovegirl Sybil Dlamini, Wolfgang P. Fendler, Matthias Eiber, Boris Hadaschik, J. Gallissian, Nader Hirmas, Scientific Data Curation Team, Martin Stuschke, Johannes Czernin, Michael L. Steinberg, Nicholas G. Nickols, Amar U. Kishan, Jérémie Calais	2024	5
4	Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers Prostate Cancer and Prostatic Diseases ·Csilla Oláh, Fabian Mairinger, R. Lander, Steven Joniau, Martin Spahn, A Mammoun, Boris Hadaschik, Shenoy Vranda, Péter Nyírády, Balázs Győrffy, Henning Reis, Tibor Szarvas	2024	3
5	Prognostic Implications of⁶⁸Ga-FAPI-46 PET/CT–Derived Parameters on Overall Survival in Various Types of Solid Tumors Journal of Nuclear Medicine ·Masao Watanabe, Wolfgang P. Fendler, Hong Grafe, Nader Hirmas, Rainer Hamacher, Scientific Data Curation Team, Kim M. Pabst, Hubertus Hautzel, Clemens Aigner, Stefan Kasper, Bastian von Tresckow, Martin Stuschke, Sherko Kümmel, Raul José da Fonseca Borges, Boris Hadaschik, Viktor Grünwald, Fadi Zarrad, Jens T. Siveke, Ken Herrmann, Manuel Weber	2024	9
6	Safety and Efficacy of Extended Therapy with [¹⁷⁷Lu]Lu-PSMA: A German Multicenter Study Journal of Nuclear Medicine ·Robert Seifert, Tsutomu Ikenohira, Constantin Lapa, Archivio di Stato di Macerata, G.G. Ephraim, Wolfgang Weber, Christian H. Pfob, Boris Hadaschik, Martin Bögemann, Michael Schäfers, Ken Herrmann, Kambiz Rahbar, Matthias Eiber, Wolfgang P. Fendler	2024	16
7	Why do surgeons need to change their intraoperative plan? A multicentric analysis of conversions in 2459 robot-assisted partial nephrectomies European Urology Open Science ·進関根, 真理子水上, D. Kim, A. L. Kazushchyk, 艾合买江, Alexandre Cobigo, Shayna Carp, Luis Miguel Chicote Serna, Andréia Menezes Olivo, Abdala Abdulkarim, 현우 김, 拓郎田内, Boris Hadaschik, Claudia Kesch, Tai-Lung Cha, Bangzheng Jiang, 王丕君, Philip Zeuschner	2023	1
8	Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysis European Urology Oncology ·Tamás Fazekas, Yanzhen Zhao, Brigitta Teutsch, J. Concepción Quiroz Ramírez, Silvia Pérez Ringuelet, Tamás Kói, Nándor Ács, Péter Hegyi, Boris Hadaschik, Péter Nyírády, Tibor Szarvas	2023	7
9	Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy Journal for ImmunoTherapy of Cancer ·S. Riazantsev, Claudia Kesch, Wolfgang P. Fendler, Tsutomu Ikenohira, Yang Liu, Vojtěch Taraba, Elai Davicioni, Jason D. Hughes, Hong Song, Katharina Lueckerath, Ken Herrmann, Boris Hadaschik, Robert Seifert	2023	4
10	Next generation radiotheranostics promoting precision medicine Annals of Oncology ·Kelsey L. Pomykala, Boris Hadaschik, Oliver Sartor, Silke Gillessen, Christopher J. Sweeney, Tim Maughan, Michael S. Hofman, Ken Herrmann	2023	42
11	Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry Cancers ·Christoph Pöttgen, Piotr Olszówka, Thomas Gauler, Maja Guberina, Nika Guberina, Surapant Meknavin, 弘明岩瀬, Ulrich Krafft, Boris Hadaschik, S.T. Indah Soesanti, Martin Stuschke	2023	5
12	Standardized PSMA-PET Imaging of Advanced Prostate Cancer Seminars in Nuclear Medicine ·Robert Seifert, Andrei Gafita, Tsutomu Ikenohira, Andrew F. Voter, Ken Herrmann, Martin G. Pomper, Boris Hadaschik, Steven P. Rowe, Wolfgang P. Fendler	2023	7
13	MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients Diagnostics ·Tibor Szarvas, Michèle J. Hoffmann, Csilla Oláh, Eszter Székely, András Kiss, Jochen Heß, Stephan Tschirdewahn, Boris Hadaschik, L. Greiller, Péter Nyírády, J. Concepción Quiroz Ramírez, A. G. M. Lam, Henning Reis	2020	11
14	Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients Diagnostics ·Csilla Oláh, Stephan Tschirdewahn, Michèle J. Hoffmann, Ulrich Krafft, Boris Hadaschik, Péter Nyírády, Attila Szendrői, Orsolya Módos, J. Concepción Quiroz Ramírez, Ilona Kovalszky, Henning Reis, Tibor Szarvas	2020	8
15	Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography–fusion Biopsy European Urology Focus ·Stephan Tschirdewahn, Manuel Wiesenfarth, David Bonekamp, Günther Pawellek, Henning Reis, Andrej Panic, Claudia Kesch, Christopher Darr, Jochen Heß, Francesco Giganti, Caroline M. Moore, Nika Guberina, Michael Forsting, Axel Wetter, Boris Hadaschik, Jan Philipp Radtke	2020	49
16	Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer Clinical Cancer Research ·Wolfgang P. Fendler, Manuel Weber, Amir Iravani, Michael S. Hofman, Jérémie Calais, Johannes Czernin, Harun Ilhan, Fred Saad, Eric J. Small, Matthew R. Smith, Antanas Burbo, Thomas A. Hope, Isabel Rauscher, Anil Londhe, Angela Lopez‐Gitlitz, Shinta Cheng, Tobias Maurer, Ken Herrmann, Matthias Eiber, Boris Hadaschik	2019	183
17	Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets Clinical Cancer Research ·Stephan Lang, Kirsten Bruderek, Reza Fadilah, Benedikt Höing, Oliver Kanaan, Nina Dominas, Timon Hussain, Freya Droege, Shafi Ahamed, Boris Hadaschik, Sven Brandau	2018	166
18	[Self-concept and erectile dysfunction in 45-year-old men : Results of a corollary study of the PROBASE trial]. PubMed ·Laura Bonati, Andreas Dinkel, Birgitt Marten‐Mittag, Andrés Cobos Díaz, Peter Albers, Christian Arsov, Boris Hadaschik, Markus Hohenfellner, Florian Imkamp, M.A. Kuczyk, Jürgen E. Gschwend, Kathleen Herkommer	2016	2
19	Patientenorientierung und Entscheidungsfindung bei lokal begrenztem Prostatakarzinom : Mögliche Felder urologischer Versorgungsforschung (Leitthema) Urologe A ·Johannes Huber, Andreas Ihrig, Christian G. Huber, Boris Hadaschik, Sascha Pahernik, Markus Hohenfellner	2011	6
20	Clusterin Facilitates COMMD1 and I-κB Degradation to Enhance NF-κB Activity in Prostate Cancer Cells Molecular Cancer Research ·Amina Zoubeidi, Susan Ettinger, Eliana Beraldi, Boris Hadaschik, Anousheh Zardan, Leo W. J. Klomp, Colleen C. Nelson, Paul S. Rennie, Martin Gleave	2010	108

About Boris Hadaschik

Boris Hadaschik is a scholar working on Pulmonary and Respiratory Medicine, Urology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Rheumatology, having authored 419 papers that have together received 13.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (212 papers), Prostate Cancer Diagnosis and Treatment (159 papers), Radiopharmaceutical Chemistry and Applications (105 papers), Bladder and Urothelial Cancer Treatments (69 papers), Urologic and reproductive health conditions (40 papers), Cancer, Lipids, and Metabolism (40 papers), Urinary and Genital Oncology Studies (32 papers) and Renal cell carcinoma treatment (29 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (10.2k citations), Radiology, Nuclear Medicine and Imaging (5.7k citations), Rheumatology (1.8k citations), Cancer Research (1.7k citations) and Urology (577 citations). Boris Hadaschik has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Uwe Haberkorn, Markus Hohenfellner, Ali Afshar‐Oromieh, Frederik L. Giesel, Klaus Kopka, Matthias Eder, Jan Philipp Radtke, Jürgen Debus, Ken Herrmann and Matthias Roethke. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging and British Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact